Director · MADRIGAL PHARMACEUTICALS, INC. · Common Stock
Side
BUY
Value
$5.34M
Shares
13.7K
Price
$388.29
Executed
Nov 6, 2026
Disclosed
Nov 6, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 6, 2026 disclosed
MDGL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Baker Bros. Advisors Lp filed this Form 4 reporting a open-market purchase of MDGL on Nov 6, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Baker Bros. Advisors Lpcik:0001263508
Issuer
MADRIGAL PHARMACEUTICALS, INC.cik:0001157601
Revision history · 0
No field has changed since this record was first ingested.
